• Q-VD-OPh: Pan-Caspase Inhibition for Mechanistic Apoptosis C

  2026-06-05

  Explore how Q-VD-OPh, a potent pan-caspase inhibitor, enables precise, mechanistically informed modulation of apoptosis in advanced research. This article uniquely bridges molecular mechanism, assay design, and translational neurodegeneration studies.

• DOT1L Inhibition Enhances Lenalidomide Response in Myeloma

  2026-06-05

  The reference study uncovers how targeting the histone methyltransferase DOT1L in multiple myeloma cells reprograms innate immunity, activating interferon pathways and enhancing the efficacy of immunomodulatory drugs such as lenalidomide. These findings establish DOT1L as a promising epigenetic target and reveal a mechanistic synergy between epigenetic modulation and immune activation in myeloma therapy.

• Sulfo-NHS-Biotin (A8001): Reliable Cell Surface Protein Labe

  2026-06-04

  This article addresses real-world challenges in cell viability and protein interaction assays, guiding biomedical researchers and lab technicians through the practical advantages of Sulfo-NHS-Biotin (SKU A8001). By integrating scenario-driven Q&A, the discussion highlights reproducibility, selectivity, and workflow efficiency, grounded in literature and product data. Discover how Sulfo-NHS-Biotin delivers reliable results for demanding cell-based experiments.

• BCKDK-STUB1-BCAT1 Axis Drives Glioblastoma Progression via P

  2026-06-04

  This study uncovers how BCKDK-mediated phosphorylation and STUB1-dependent ubiquitination cross-talk to regulate BCAT1 stability, promoting glioblastoma (GBM) progression. The findings provide mechanistic insight into metabolic enzyme control in cancer and suggest new intervention points for translational research.

• EZ Cap™ Cre mRNA (m1Ψ): Protocols and Innovations in Gene Ed

  2026-06-03

  EZ Cap™ Cre mRNA (m1Ψ) delivers high-efficiency, low-immunogenicity Cre recombinase expression for gene editing and functional research, outperforming conventional mRNA approaches. This guide details advanced workflow strategies, troubleshooting insights, and leverages new delivery innovations for extrahepatic targeting.

• NVP-BGJ398 Phosphate: FGFR Inhibition in Cancer and Bone Dis

  2026-06-03

  NVP-BGJ398 phosphate stands out as a powerful, pan-selective FGFR inhibitor, enabling detailed dissection of FGFR-driven signaling in cancer and skeletal disorders. Recent translational studies reveal its dual value in both oncology and rare cartilage diseases, with actionable insights for optimizing experimental design and troubleshooting.

• Mastering DNA Synthesis: Advanced Insights on 10 mM dNTP Mix

  2026-06-02

  Explore the scientific and practical advantages of the 10 mM dNTP mixture in high-fidelity DNA synthesis. This in-depth article reveals unique mechanistic insights and advanced protocol optimization, setting it apart from conventional guidance.

• Cy7 NHS Ester: Protocols for Near-Infrared Protein Labeling

  2026-06-02

  Cy7 NHS ester is a hydrophilic, sulfonated near-infrared dye that enables efficient, water-based fluorescent labeling of proteins and peptides for imaging and tracking applications in vitro and in vivo. It addresses the challenge of labeling delicate, denaturation-prone biomolecules without organic co-solvents. This reagent is not recommended for workflows requiring long-term storage of dye solutions or for targets lacking accessible amino groups.

• ECL Western Blotting Substrate: Technical Workflow and QC Gu

  2026-06-01

  ECL Western Blotting Substrate (SKU K2187) is designed for sensitive, nonradioactive detection of HRP-labeled proteins by chemiluminescence. It is ideal for Western blot assays in molecular, cancer biology, and signal transduction studies, but is not suitable for fluorescent or radioisotopic detection methods.

• Neuroligin 1, Striatal D2-MSNs, and Repetitive Behaviors in

  2026-06-01

  This study identifies the loss of Neuroligin 1 in striatal D2 medium spiny neurons as a driver of autistic-like repetitive behaviors through aberrant neuronal activation and downstream PKC overactivation. By dissecting the cellular and molecular mechanisms, the work clarifies how distinct neural activity patterns contribute to self-grooming and digging behaviors, laying groundwork for targeted interventions in ASD.

• Carvedilol Phosphate in Ischemia–Reperfusion Injury Models

  2026-05-31

  Carvedilol Phosphate is a high-purity non-selective beta blocker that empowers advanced modeling of ischemia–reperfusion injury (IRI) and GPCR signaling in cardiovascular and hepatic research. This guide translates recent mechanistic breakthroughs into actionable protocols, troubleshooting strategies, and workflow optimizations for preclinical investigators.

• Bortezomib (PS-341): Optimizing Proteasome Inhibition Workfl

  2026-05-30

  Bortezomib (PS-341) is a gold-standard proteasome inhibitor, offering precise control in apoptosis and cancer cell viability assays. This article delivers advanced workflow optimizations and troubleshooting for achieving reproducible results in proteasome-regulated cellular process research, highlighting critical protocol choices informed by recent evidence.

• InstaBlue Protein Stain Solution: Rapid Coomassie Gel Staini

  2026-05-29

  InstaBlue Protein Stain Solution addresses the need for ultra-fast, sensitive, and non-toxic visualization of proteins in polyacrylamide gels, eliminating time-consuming fixation and destaining steps. This reagent is ideal for workflows prioritizing speed, downstream compatibility, and environmental safety, but should not be substituted where alternative detection chemistries or pre-cast gel formats are mandatory.

• Homoharringtonine as a Rapid SARS-CoV-2 Inhibitor: Molecular

  2026-05-29

  A recent study demonstrates that homoharringtonine, a cytotoxic alkaloid previously established in leukemia research, rapidly clears SARS-CoV-2 from the upper respiratory tract in both animal models and human patients. These findings highlight its translational potential as a first-line antiviral intervention and establish a mechanistic bridge between oncology and infectious disease research.

• (S)-(+)-Dimethindene maleate: Protocols for M2 Antagonist Us

  2026-05-28

  (S)-(+)-Dimethindene maleate is a highly selective M2 muscarinic receptor antagonist with additional H1 histamine receptor blocking properties. This reagent addresses the need for precise modulation of muscarinic acetylcholine signaling in autonomic regulation research. It is not suitable for diagnostic or clinical applications and should be used solely for in vitro or ex vivo scientific studies.

16429 records 1/1096 page Next 12345 下5页 Last page